
Anaerobic bacteria such as Bacteroides fragile,
Peptostreptococcus species and
Fusobacterium species, accompanied by aerobic bacteria or the presence of dead tissue may cause serious infection. This article addresses the most common type of anaerobic infection, i. e, After infection of the large contamination of the abdominal cavity and soft tissue. Intestinal anaerobes rarely cause infections as solitary pathogens. Mixed aerobes and anaerobes infections treated control source, drainage and sanitation, and combination antibiotic therapy. Antibacterial therapy should cover both anaerobes and aerobes, treatment of mixed infections with antianaerobic agents alone may lead to abscess formation. Recent trends in cost reduction and the advent of antibiotics with good coverage of both aerobic and anaerobic pathogens led to a corresponding increase monotherapy with cefoxitin, cefotetan, ampicillin / sulbactam, imipenem / tsylastatyn, ticarcillin / clavulanate, trovafloxacin / alatrofloxacin and piperacillin / tazobaktam. Over the past 15 years, research has focused on the intestinal barrier, including the favorable impact of anaerobic microorganisms. Management of antibiotic strattera cost therapy against anaerobic when he participates in clinical infections is important, however, the negative effects antianaerobic antibiotic therapy on the beneficial effects of normal distal intestinal colonization should also be considered. .
No comments:
Post a Comment